Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Sistemas de administración de fármacos novedosos y precisos para inyecciones en la capa dérmica de la piel

Resumen

Tipo:
Oferta Tecnológica
Referencia:
TOBE20170825001
Publicado:
18/10/2017
Caducidad:
18/10/2018
Resumen:
Una pyme belga ha desarrollado un sistema preciso de administración de fármacos destinado a campos terapéuticos como tratamiento de enfermedades infecciosas, terapia celular para enfermedades genéticas, pruebas intradérmicas de alergias e inyecciones antiinflamatorias en enfermedades de la piel. El sistema se encuentra en fase de prototipo. Después de llevar a cabo un estudio de prueba de concepto exitoso, la empresa está realizando los trámites para obtener el marcado CE y el registro de la FDA. Se buscan institutos de investigación y compañías farmacéuticas y biotecnológicas que precisen un sistema preciso de administración transdermal.


Details

Tittle:
Innovative and accurate drug delivery systems suited for injections in the dermal layer of the skin.
Summary:
A Belgian SME has developed an accurate drug delivery system in therapeutic fields such as: treatment of infectious diseases, cell therapy for genetic diseases, intradermal allergy testing and anti-inflammatory injections in skin diseases. Currently in prototyping phase. After a successful Proof-of-Concept study using a HepB Vaccine, now preparing for CE-marking and FDA registration. They are looking for partnerships with Pharma -Y- Biotech companies -Y- research institutes.
Description:
Belgian based company produces a device that consists of injection moulded parts (medical grade plastics) and a stainless-steel needle which is manufactured in Japan. Assembly, packaging and batch release of fully finished end-product is done at the Headquarters in Belgium.
A platform of variants is being prepared depending on needle characteristics (length - thickness) and a prefilled/non-prefilled/ lyophilized two-chamber variant. By varying the thickness, actual cells as therapeutic agents can be included. Depending on the variant it can be used in different clinical therapeutic areas.

This can lead to a broader possible commercial market, not only human but also veterinary applications.
Targeted therapeutic areas: treatment of infectious diseases (e.g. polio), cell therapy for genetic diseases like MS, intradermal allergy testing and anti-inflammatory injections in skin diseases
They are actively looking for pharma and biotech companies that are looking for solutions to deliver their drugs intradermally. Similarly, we are seeking collaboration with research institutes to enable interaction and partnerships.
Advantages and Innovations:
The company is a leader in user-friendly and game-changing medical device solutions for drugs delivery systems in the skin with a unique design, that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user. The company is linked to a University, endorsed on multiple occasions nationally and internationally for its solutions.
The medical device with an original design is a delivery device suited for standardized and guaranteed delivery of small volumes of drugs (i.e. vaccine). The device is designed in such a way that it is easy to use (perpendicular on the skin, one click method).
Stage of Development:
Prototype available for demonstration
IPs:
Patent(s) applied for but not yet granted,Patents granted,Trade Marks
CommeR Statunts Regarding IPR Status:
In the Benelux region, they have a registered trademark for the commercial brand name and logo as well as for the company name and logo, other countries are pending. The aim is to further expand the patent portfolio covering the new variants they are developing.

Partner sought

Type and Role of Partner Sought:
The Belgian company is actively seeking partnerships and collaborations with pharma and biotech companies as well as R-Y-D organisations that are in need for an accurate drug delivery system targeting the dermal layer of the skin.
We are looking for distribution and commercial potential partnerships.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
Dutch
English
French
Italian
Japanese
Portuguese
Spanish

Keywords

Technology Keywords:
06001013 Tecnología médica / ingeniería biomédica